CVS Health topped fourth-quarter earnings estimates, but its profit slid 38% from last year. Despite this, the pharmacy chain’s new CEO offered a promising outlook for 2025 growth. This positive signal helped boost CVS stock to become the No. 1 performing S&P 500 company. Although the earnings beat was not as strong as analysts had anticipated, it still made the company’s stock stand out in the market.
Source: https://www.investors.com/news/cvs-stock-cvs-health-earnings-q4-2025-outlook